SCHEMBL6838565

SCHEMBL6838565

FC(F)(F)c1nc2cc(Cl)ccc2c2c1nc(-c1cccs1)n2CCN1CCNCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 2/20 0.42
KDM4E B2RXH2 2/20 0.35
HTT P42858 2/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
GBA1 P04062 1/20 0.34
LMNA P02545 2/20 0.33
PBK Q96KB5 1/20 0.33
NPC1 O15118 1/20 0.32
NLRP3 Q96P20 2/20 0.32
HRH1 P35367 1/20 0.32
HRH4 Q9H3N8 1/20 0.32
KMT2A Q03164 1/20 0.32
ATM Q13315 1/20 0.32
CYP1A2 P05177 2/20 0.32
CYP2D6 P10635 1/20 0.32
SOS1 Q07889 1/20 0.32
KCNH2 Q12809 1/20 0.31
EIF4EBP1 Q13541 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6838640 0.91 KCNH2 (0.37) HTR6KDM4EALDH1A1HPGDNPSR1
SCHEMBL6837935 0.91 HTR6 (0.36) HTR6KDM4EHTTALDH1A1HPGD
SCHEMBL6838050 0.87 HTR6 (0.38) HTR6KDM4EHTTALDH1A1HPGD
SCHEMBL6837641 0.86 EGFR (0.42) HTR6KDM4EHTTALDH1A1HPGD
SCHEMBL6838395 0.86 EIF4EBP1 (0.35) HTR6LMNAKMT2AATMCYP1A2
SCHEMBL6838576 0.84 KMT2A (0.33) HTR6LMNAKMT2AATMCYP1A2
SCHEMBL6838072 0.83 HRH1 (0.35) KDM4EHTTALDH1A1HPGDNPSR1
SCHEMBL6837670 0.82 HTR6 (0.34) HTR6KDM4EHTTALDH1A1HPGD
SCHEMBL6833788 0.82 ADRB2 (0.35) KMT2AATMCYP1A2CYP2D6SOS1
SCHEMBL6838712 0.82 HTR6 (0.37) HTR6KDM4EHTTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040054182-A1 1h-imidazopyridine derivatives HOKURIKU SEIYAKU CO., LTD. (JP) 2004-03-18 US disclosed
EP-1256582-A1 1H-IMIDAZOPYRIDINE DERIVATIVES HOKURIKU SEIYAKU CO., LTD. (JP) 2002-11-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040054182-A1 1h-imidazopyridine derivatives IL2, IL1A, IL4 HTR6 3067/4885KDM4E 2253/4885HTT 4393/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.